These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8389764)
1. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Takumi T; Moustakas A; Lin HY; Lodish HF Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622 [TBL] [Abstract][Full Text] [Related]
3. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. Xu J; McKeehan K; Matsuzaki K; McKeehan WL J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768 [TBL] [Abstract][Full Text] [Related]
4. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624 [TBL] [Abstract][Full Text] [Related]
5. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304 [TBL] [Abstract][Full Text] [Related]
7. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742 [TBL] [Abstract][Full Text] [Related]
8. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Xu J; Matsuzaki K; McKeehan K; Wang F; Kan M; McKeehan WL Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7957-61. PubMed ID: 8058741 [TBL] [Abstract][Full Text] [Related]
9. Identification and cloning of a novel type I serine/threonine kinase receptor of the TGF-beta/BMP superfamily in rat prostate. Kang Y; Reddi AH Biochem Mol Biol Int; 1996 Nov; 40(5):993-1001. PubMed ID: 8955889 [TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta superfamily receptors in dental pulp. Toyono T; Nakashima M; Kuhara S; Akamine A J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489 [TBL] [Abstract][Full Text] [Related]
11. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. Lux A; Attisano L; Marchuk DA J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774 [TBL] [Abstract][Full Text] [Related]
12. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. ten Dijke P; Yamashita H; Sampath TK; Reddi AH; Estevez M; Riddle DL; Ichijo H; Heldin CH; Miyazono K J Biol Chem; 1994 Jun; 269(25):16985-8. PubMed ID: 8006002 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 selectively increases gene expression of the serine/threonine kinase receptor 1 (SKR1) in human hepatoma cell lines. Inagaki M; Wang Z; Carr BI Cell Struct Funct; 1994 Oct; 19(5):305-13. PubMed ID: 7850892 [TBL] [Abstract][Full Text] [Related]
14. Characterization of type I receptors for transforming growth factor-beta and activin. ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412 [TBL] [Abstract][Full Text] [Related]
16. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. ten Dijke P; Ichijo H; Franzén P; Schulz P; Saras J; Toyoshima H; Heldin CH; Miyazono K Oncogene; 1993 Oct; 8(10):2879-87. PubMed ID: 8397373 [TBL] [Abstract][Full Text] [Related]
17. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Mathews LS; Vale WW Cell; 1991 Jun; 65(6):973-82. PubMed ID: 1646080 [TBL] [Abstract][Full Text] [Related]
18. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins. Chen Y; Lebrun JJ; Vale W Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12992-7. PubMed ID: 8917532 [TBL] [Abstract][Full Text] [Related]
19. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. He WW; Gustafson ML; Hirobe S; Donahoe PK Dev Dyn; 1993 Feb; 196(2):133-42. PubMed ID: 8395914 [TBL] [Abstract][Full Text] [Related]
20. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Koenig BB; Cook JS; Wolsing DH; Ting J; Tiesman JP; Correa PE; Olson CA; Pecquet AL; Ventura F; Grant RA Mol Cell Biol; 1994 Sep; 14(9):5961-74. PubMed ID: 8065329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]